News & Updates
Filter by Specialty:
Sotrovimab of no help in attenuating COVID-19 severity in face of Omicron BA.2 subvariant
Treatment with sotrovimab does not appear to confer protection against severe forms of COVID-19 in a setting dominated by the Omicron BA.2 subvariant, a study has found.
Sotrovimab of no help in attenuating COVID-19 severity in face of Omicron BA.2 subvariant
26 Sep 2022
Vaccine-preventable diseases cause most hospitalizations in IBD patients
Many infectious disease-related hospital admissions in patients with inflammatory bowel disease may have been prevented by immunization, suggests a study.
Vaccine-preventable diseases cause most hospitalizations in IBD patients
24 Sep 2022
Low zinc, vitamin D levels may predict susceptibility to COVID-19
Patients with COVID-19 show very low levels of 25-hydroxyvitamin D and zinc, regardless of age, sex, and comorbidities, reports a study. Vitamin D and zinc deficiency appears to be relevant factors in identifying individuals who are susceptible to SARS-CoV-2 infection.
Low zinc, vitamin D levels may predict susceptibility to COVID-19
23 Sep 2022
DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults
Older adults who receive a high-dose quadrivalent influenza vaccine have a 49 percent reduced risk of death and a 64 percent reduced risk of hospitalization for influenza or pneumonia compared with those who receive a standard-dose vaccine, results of the DANFLU-1 study showed.
DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults
22 Sep 2022
Inhaled IFN-β1a shows favourable signals for hospitalized COVID-19 patients
In the phase III SPRINTER trial, inhaled interferon-beta-1a (IFN-β1a) showed encouraging signals for preventing disease progression or death in hospitalized COVID-19 patients.
Inhaled IFN-β1a shows favourable signals for hospitalized COVID-19 patients
22 Sep 2022
Real-world HK study: Nirmatrelvir/ritonavir reduces hospitalizations in COVID-19 patients
The oral antiviral nirmatrelvir/ritonavir, but not molnupiravir, reduces the risk of hospitalization among community COVID-19 patients in Hong Kong, a real-world territory-wide retrospective cohort study has shown.
Real-world HK study: Nirmatrelvir/ritonavir reduces hospitalizations in COVID-19 patients
22 Sep 2022
Awake prone positioning helps avoid mechanical ventilation in COVID-19
Keeping COVID-19 patients in the prone position even while they are awake appears to reduce the need for invasive mechanical ventilation (IMV), according to a recent Singapore study.
Awake prone positioning helps avoid mechanical ventilation in COVID-19
21 Sep 2022
Trichomoniasis infection ups prostate cancer, benign prostate hyperplasia risk
Men with Trichomoniasis vaginalis infections appear to be at an elevated risk of prostate cancer (PCa) and benign prostate hyperplasia (BPH), according to a recent study.
Trichomoniasis infection ups prostate cancer, benign prostate hyperplasia risk
20 Sep 2022
Female gout patients at higher risk of SARS-CoV-2 infection, severe sequelae
Despite being vaccinated against COVID-19, women with gout have an excess risk of developing SARS-CoV-2 infection as well as severe sequelae from it, according to a study.